Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Ovarian Neoplasms 1Endodermal Sinus Tumor 1Central Nervous System Neoplasms 1

Interventions

Paclitaxel 8Filgrastim 8Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Ifosfamide 6Etoposide 4Temozolomide 3pembrolizumab 2pegfilgrastim 2ixabepilone 2etoposide phosphate 2Thiotepa 2Melphalan 2Gemcitabine 2Cisplatin 2Amifostine 2sodium thiosulfate 1regorafenib 1carboxyamido-triazole 1aflibercept 1Trabectedin 1Topotecan 1Taxes 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PT-100 dipeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Lenograstim × Gynecologic × Clear all
NCT00551122 2013-01-23

GemTIP

University of Southampton

Phase 1/2 Unknown
23 enrolled
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms, Central Nervous System Neoplasms, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡